FDX
40
4
CAT
62
7
PCAR
56
3
QRVO
8
4
MLM
51
3
WDC
43
2
RRC
59
-4
GOOG
53
-12
NSC
57
7
VRSN
57
4
CMG
67
3
ROST
52
5
EQIX
62
2
COST
63
5
ROK
47
-8
BXP
52
2
CVS
50
2
HSIC
51
-3
AMAT
42
6
DVN
18
2
FDX
40
4
CAT
62
7
PCAR
56
3
QRVO
8
4
MLM
51
3
WDC
43
2
RRC
59
-4
GOOG
53
-12
NSC
57
7
VRSN
57
4
CMG
67
3
ROST
52
5
EQIX
62
2
COST
63
5
ROK
47
-8
BXP
52
2
CVS
50
2
HSIC
51
-3
AMAT
42
6
DVN
18
2
Financhill
Back

CV Sciences Vs. Perspective Therapeutics Industry Stock Comparison

Sell
37

CVSI
CV Sciences

Last Price:
0.05
Seasonality Move:
0.63%
Sell
30

CATX
Perspective Therapeutics

Last Price:
2.99
Seasonality Move:
34.33%
Sell
37
CV Sciences (CVSI) is a Sell

Is CV Sciences a Buy, Sell or Hold?

  • The current CV Sciences [CVSI] share price is $0.04. The Score for CVSI is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • CVSI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $3.00. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CVSI Stock Price Chart

What is CV Sciences's stock price today?

  • The CV Sciences share price today is $0.04
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CVSI is experiencing selling pressure, which indicates risk of future bearish movement.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $3.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.

CVSI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0 Sell
Relative Strength Index (14 RSI): 49.31 Sell
Chaikin Money Flow: 61531 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.05 - 0.05) Sell
Bollinger Bands (100): (0.05 - 0.05) Sell

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.83 Sell
Relative Strength Index (14 RSI): 9.64 Sell
Chaikin Money Flow: -11653674 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.08 - 12.98) Sell
Bollinger Bands (100): (10.5 - 14.68) Sell

CVSI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.04 Buy
20-day SMA: 0.05 Sell
50-day SMA: 0.05 Sell
200-day SMA: 0.05 Sell
8-day EMA: 0.04 Buy
20-day EMA: 0.04 Buy
50-day EMA: 0.05 Sell
200-day EMA: 0.05 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 7.54 Sell
20-day SMA: 10.1 Sell
50-day SMA: 11.82 Sell
200-day SMA: 12.75 Sell
8-day EMA: 7.04 Sell
20-day EMA: 9.29 Sell
50-day EMA: 11.19 Sell
200-day EMA: 11.43 Sell

CV Sciences Earnings Growth & CVSI Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.78 per share, and a decrease next year of $0.49 per share.

CV Sciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):